Overview of Hymecromone Sopharma
Quick Facts
| Property | Description |
|---|---|
| Active ingredient | Hymecromone (7-Hydroxy-4-methylcoumarin) |
| Form | Solid Oral Tablet |
| Pharmacological Class | Choleretic Agent, Biliary Antispasmodic |
| Common Use | Normalizing bile flow and relieving biliary spasm |
| Origin | Synthetic Coumarin Derivative |
What is Hymecromone and What Type of Drug is It?
Hymecromone Sopharma is a pharmaceutical product containing the active substance Hymecromone (INN), typically manufactured by Sopharma and utilized in various international markets. Chemically, the compound is identified as a synthetic coumarin derivative that structurally distinguishes itself from anticoagulant coumarins, focusing its therapeutic effects strictly on the biliary system. Pharmacologically, Hymecromone is recognized as a dual-action agent: a specialized choleretic agent and a biliary antispasmodic. This classification ensures its action is specialized for supporting digestive processes via bile management.
Hymecromone acts by increasing the output of bile from the liver (choleretic action). This functionality supports the steady flow of bile and addresses issues associated with its stagnation.
Composition, Form, and General Purpose
The medication is a single-component monotherapy, containing only the active ingredient Hymecromone, and is administered via the oral route, typically supplied as a solid tablet. The core function is rooted in two complementary effects recognized to address biliary tract issues: the stimulation of bile production and the relaxation of smooth muscle in the bile ducts and the sphincter of Oddi (antispasmodic action).
This combination of effects serves the general purpose of restoring and supporting proper bile movement and flow. A typical use scenario involves helping individuals whose digestive discomfort stems from impaired bile transport or functional spasm within the biliary tract, providing a consistent means to deliver this specialized action to the digestive system.

